Diabetic neuropathy is one of the most common diabetes mellitus complications associated with mediocalcinosis of the lower extremities, a significant decrease in feet bone mineral density, and a high incidence of cardiovascular disease. In most cases, calcium-phosphorus metabolism changes occur in patients with diabetic neuroarthropathy, or Charcot foot, when we can observe feet local osteoporosis, which in 90% of cases associated with a vessel's calcification of the lower extremities in the majority of diabetes population. A large number of studies presented literature have demonstrated that patients with Charcot foot can have accelerated bone metabolism and increased bone resorption. Patients with Charcot foot often have crucial abnormalities in the calcium-phosphorus parameters, bone metabolism, and levels of vitamin D and its metabolites. In addition, the duration of diabetes mellitus, the degree of its compensation widely affects the development of its micro- and macrovascular complications, which could also accelerate the development of mineral and bone disorders in these types of patients. Multifactorial pathogenesis of these disorders complicates the management of patients with a long and complicated course of diabetes mellitus. This review discusses the peculiarities of vitamin D metabolism, the importance of timely diagnosis in phosphorus-calcium disorders, and the specifics of therapy in these patients. Special attention is paid to the timely diagnosis of the Charcot's foots acute stage based on the bone marrow edema by MRI evaluation and the possibility of reducing the immobilization period.
Keyphrases
- bone mineral density
- postmenopausal women
- cardiovascular disease
- body composition
- end stage renal disease
- type diabetes
- soft tissue
- bone marrow
- chronic kidney disease
- newly diagnosed
- glycemic control
- risk factors
- magnetic resonance imaging
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- ms ms
- metabolic syndrome
- hepatitis b virus
- skeletal muscle
- magnetic resonance
- computed tomography
- coronary artery disease
- contrast enhanced
- drug induced
- weight loss
- heavy metals
- cell therapy
- cardiovascular risk factors